Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22
Phase 33

Trial Status

Completed2
Terminated1
Other1

Role Distribution

Principal Investigator4
PI Rate100%

Activity Timeline

Clinical Trials (4)

NCT02764411Phase 3Terminated
Onreltea (Brimonidine) Gel In Pediatric Patients With Capillary Malformations
Capillary Malformations
PrincipalinvestigatorStart date: 2016-06-01
NCT00147771Phase 3Completed
Imiquimod in Children With Plaque Morphea
Scleroderma, Localized
Principalinvestigator
NCT01010308Phase 2Completed
Nadolol for Proliferating Infantile Hemangiomas
Infantile Hemangioma
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT02764411Phase 3PrincipalInvestigator

Onreltea (Brimonidine) Gel In Pediatric Patients With Capillary Malformations

Capillary Malformations
Terminated
NCT00147771Phase 3PrincipalInvestigator

Imiquimod in Children With Plaque Morphea

Scleroderma, Localized
Completed
NCT01010308Phase 2PrincipalInvestigator

Nadolol for Proliferating Infantile Hemangiomas

Infantile Hemangioma
Completed
NCT04613102Phase 2/3PrincipalInvestigator

The Efficacy and Safety of 3% Cannabidiol (CBD) Cream in Patients With Epidermolysis Bullosa: A Phase II/III Trial

Epidermolysis BullosaItchPain
Withdrawn

All 4 trials loaded